The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.
Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
Several major drugmakers have restricted commercially insured patients from their patient assistance programs, leaving ...
Patient outcomes appeared to be more heavily driven by breast cancer stage than delays in diagnosis, researchers found.
The American Cancer Society is asking North Dakota State lawmakers to pass legislation that would require insurance companies to cover diagnostic testing for people who need it when doctors find ...
In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...
It’s been months in the making, but now the new resource is available for those battling the treatable, but incurable form of ...
The American Cancer Society's report shows a mix of lower death rates and rising cancer incidence rates for some groups, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback